Non categorizzato Veru soars over 25% as FDA discusses its COVID drug Novembre 7, 2022 0 commenti The shares of pharma company Veru Inc. jumped more than 25% on Monday on the news the United States Food and Drugs Administration began discussions on approving its COVID-19 treatment. The FDA’s … About the author:
Get involved!
Comments